Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies.

Sebastian P HaenVicky EybNora MirzaAline NaumannAndreas PeterMarkus W LöfflerChristoph FaulWichard VogelWolfgang A BethgeHans-Georg RammenseeLothar KanzMartin Heni

Published in: Journal of cancer research and clinical oncology (2017)

Changes in UA serum levels can indicate incipient or remaining immunological activity after HCT or induction therapy. They may, therefore, help to differentiate between PGF and GF.

Keyphrases

uric acid
bone marrow
metabolic syndrome
mesenchymal stem cells
stem cells
cell cycle arrest
cell proliferation
signaling pathway
cell therapy